| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1024698061 |
| P356 | DOI | 10.1186/1748-717X-8-11 |
| P932 | PMC publication ID | 3552734 |
| P698 | PubMed publication ID | 23298438 |
| P5875 | ResearchGate publication ID | 234088113 |
| P2093 | author name string | Seung Kew Yoon | |
| Chul Seung Kay | |||
| Jeong Won Jang | |||
| Byung Ock Choi | |||
| Hong Seok Jang | |||
| Seok Hyun Son | |||
| Jin Ho Song | |||
| Sea-Won Lee | |||
| Young Nam Kang | |||
| P2860 | cites work | Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma | Q33327962 |
| A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases | Q33501012 | ||
| Estimating the world cancer burden: Globocan 2000. | Q34518922 | ||
| Lamivudine for patients with chronic hepatitis B and advanced liver disease | Q34551713 | ||
| Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. | Q34714683 | ||
| Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma | Q40089589 | ||
| Hepatic toxicity resulting from cancer treatment. | Q40505524 | ||
| Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy. | Q43780887 | ||
| Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients | Q43850818 | ||
| Analysis of radiation-induced liver disease using the Lyman NTCP model. | Q44048914 | ||
| Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience | Q44275531 | ||
| Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child–Pugh Grade A cirrhosis | Q45867321 | ||
| Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. | Q53528172 | ||
| Local radiotherapy for patients with unresectable hepatocellular carcinoma. | Q53592416 | ||
| Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma | Q73764961 | ||
| Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients | Q74543135 | ||
| Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication | Q74619620 | ||
| Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinoma | Q81239771 | ||
| Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication | Q83145328 | ||
| Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance | Q83322582 | ||
| P921 | main subject | helical tomotherapy | Q108575067 |
| P304 | page(s) | 11 | |
| P577 | publication date | 2013-01-09 | |
| P1433 | published in | Radiation Oncology | Q2313370 |
| P1476 | title | Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma | |
| P478 | volume | 8 |
| Q36811589 | Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinoma |
| Q37176354 | Identification of Biologically Effective Dose-Volumetric Parameters That Predict Radiation-Induced Hepatic Toxicity in Patients Treated With Helical Tomotherapy for Unresectable Locally Advanced Hepatocellular Carcinoma |
| Q36561787 | Identifying the optimal criteria of radiotherapeutic parameters for patients with unresectable locally advanced hepatocellular carcinoma |
| Q41709047 | Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results |
| Q36545343 | Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapy |
| Q33593108 | Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma |
| Q64902147 | Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies. |
| Q39231208 | What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy |
Search more.